Failure of atovaquone-proguanil malaria chemoprophylaxis in a traveler to Ghana

被引：11
|
作者：
Boggild, Andrea K. [1 ,2 ,3 ]
Lau, Rachel [3 ]
Reynaud, Denis [4 ]
Kain, Kevin C. [1 ,2 ,5 ]
Gerson, Marvin [6 ]
机构：
[1] Univ Hlth Network, Toronto Gen Hosp, Div Infect Dis, Trop Dis Unit, Toronto, ON, Canada
[2] Univ Toronto, Dept Med, Toronto, ON, Canada
[3] Publ Hlth Ontario, Publ Hlth Ontario Labs, Toronto, ON, Canada
[4] Hosp Sick Children, Ctr Study Complex Childhood Dis, Toronto, ON M5G 1X8, Canada
[5] Univ Toronto, Sandra Rotman Ctr Global Hlth, Sandra A Rotman Labs, Toronto, ON M5S 1A1, Canada
[6] Humber River Hosp, N York, ON, Canada
来源：
TRAVEL MEDICINE AND INFECTIOUS DISEASE | 2015年 / 13卷 / 01期
关键词：
Drug resistance; Malabsorption; Malaria; Malarone; Plasmodium falciparum; TIME QUANTITATIVE PCR; GENE COPY NUMBER; PLASMODIUM-FALCIPARUM; GEOSENTINEL SURVEILLANCE; RETURNED TRAVELERS; TREATMENT POLICY; RESISTANCE; CHLOROQUINE; CHILDREN; DISEASES;
D O I：
10.1016/j.tmaid.2014.12.010
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
Clinical failure of Malarone (TM) chemoprophylaxis is extremely rare. We report a case of Plasmodium falciparum malaria in a returned traveler to Ghana who fully adhered to atovaquone-proguanil (Malarone (TM)) chemoprophylaxis daily dosing, yet took the pills on an empty stomach. Screening of the P. falciparum isolate revealed triple codon mutation of Dhfr at positions 51, 59, and 108. Plasma drug levels of both atovaquone and proguanil revealed sub-therapeutic concentrations. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码：89 / 93
页数：5
相关论文
共 50 条
  • [1] Malaria Chemoprophylaxis With Atovaquone-Proguanil: Is a Shorter Regimen Fully Protective?
    Grobusch, Martin P.
    JOURNAL OF TRAVEL MEDICINE, 2014, 21 (02) : 79 - 81
  • [2] Vivax Malaria Chemoprophylaxis: The Role of Atovaquone-Proguanil Compared to Other Options
    Meltzer, Eyal
    Rahav, Galia
    Schwartz, Eli
    CLINICAL INFECTIOUS DISEASES, 2018, 66 (11) : 1751 - 1755
  • [3] Atovaquone-proguanil chemoprophylaxis in the era of Tafenoquine
    Meltzer, Eyal
    Schwartz, Eli
    JOURNAL OF TRAVEL MEDICINE, 2019, 26 (04)
  • [4] Early treatment failure during treatment of Plasmodium falciparum malaria with atovaquone-proguanil in the Republic of Ivory Coast
    Wurtz, Nathalie
    Pascual, Aurelie
    Marin-Jauffre, Adeline
    Bouchiba, Housem
    Benoit, Nicolas
    Desbordes, Marc
    Martelloni, Maryse
    de Santi, Vincent Pommier
    Richa, Georges
    Taudon, Nicolas
    Pradines, Bruno
    Briolant, Sebastien
    MALARIA JOURNAL, 2012, 11
  • [5] Atovaquone-proguanil resistance in imported falciparum malaria in a young child
    Rose, Gregory W.
    Suh, Kathryn N.
    Kain, Kevin C.
    Le Saux, Nicole
    McCarthy, Anne E.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2008, 27 (06) : 567 - 569
  • [6] Early treatment failure during treatment of Plasmodium falciparum malaria with atovaquone-proguanil in the Republic of Ivory Coast
    Nathalie Wurtz
    Aurélie Pascual
    Adeline Marin-Jauffre
    Housem Bouchiba
    Nicolas Benoit
    Marc Desbordes
    Maryse Martelloni
    Vincent Pommier de Santi
    Georges Richa
    Nicolas Taudon
    Bruno Pradines
    Sébastien Briolant
    Malaria Journal, 11
  • [7] Atovaquone-proguanil for prophylaxis and treatment of malaria
    Marra, F
    Salzman, JR
    Ensom, MHH
    ANNALS OF PHARMACOTHERAPY, 2003, 37 (09) : 1266 - 1275
  • [8] Fluindione and falciparum malaria treated by atovaquone-proguanil
    Kamaliddin, Claire
    Joste, Valentin
    Argy, Nicolas
    Houze, Sandrine
    THERAPIE, 2018, 73 (05): : 445 - 447
  • [9] Atovaquone-proguanil treatment failure in Plasmodium folciporum
    Contentin, Laetitia
    Grammatico-Guillon, Leslie
    Desoubeaux, Guillaume
    Baron, Sabine
    Hai Duong Thanh
    PRESSE MEDICALE, 2011, 40 (11): : 1081 - 1083
  • [10] Atovaquone-proguanil for treating uncomplicated Plasmodium falciparum malaria
    Blanshard, Andrew
    Hine, Paul
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (01):
12345